What is Evommune 's total equity?

Evommune (EVMN) reported total equity of -$4.51M in Q1 2026.

How has Evommune 's total equity changed year-over-year?

Evommune 's total equity decreased by 3048.0% year-over-year, from $153.01K to -$4.51M.

What is the long-term trend for Evommune 's total equity?

Over 2 years (2023 to 2025), Evommune 's total equity has grown at a 671.7% compound annual growth rate (CAGR), from $25.88K to $1.54M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Evommune EVMN Total Equity

Total Equity at other companies

PfizerPFE

$90.1B-0.3%

Bausch + LombBLCO

$6.38B+0.3%

BillionToOne, Inc. BLLN

$505.62M+300%

Perrigo CompanyPRGO

$2.5B-42.7%

Hims & Hers HealthHIMS

$446.17M-18.8%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's total equity?: Evommune (EVMN) reported total equity of -$4.51M in Q1 2026.
How has Evommune 's total equity changed year-over-year?: Evommune 's total equity decreased by 3048.0% year-over-year, from $153.01K to -$4.51M.
What is the long-term trend for Evommune 's total equity?: Over 2 years (2023 to 2025), Evommune 's total equity has grown at a 671.7% compound annual growth rate (CAGR), from $25.88K to $1.54M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.